Abstract
Dual-parameter flow cytometry, following bromodeoxyuridine (BrdUrd) incorporation and propidium iodide (PI) uptake into DNA, was used to study the effects of oestradiol and/or insulin on cell cycle kinetics of human breast cancer cells in vitro. After a lag-period of 6-12 h, an optimum in the percentage of S-phase cells was reached between 18 and 24 h after hormone administration. A 1 h pulse of oestradiol was as effective as the continuous presence of oestradiol in pushing the cells from quiescent growing cultures into the cell cycle. A 1 h pulse of insulin was less effective than continuous administration. The addition of doxorubicin resulted in an accumulation of the cells in the late S/G2M-phases. It is concluded that dual-parameter flow cytometry allows accurate assessment of the effects of hormones and chemotherapy on the cell cycle. Therefore this method is very suitable for studying the interaction of hormones and chemotherapy on cell growth.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bontenbal M., Sonneveld P., Foekens J. A., Klijn J. G. Oestradiol enhances doxorubicin uptake and cytotoxicity in human breast cancer cells (MCF-7). Eur J Cancer Clin Oncol. 1988 Sep;24(9):1409–1414. doi: 10.1016/0277-5379(88)90329-x. [DOI] [PubMed] [Google Scholar]
- Clarke R., Van den Berg H. W., Kennedy D. G., Murphy R. F. Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol. Br J Cancer. 1985 Mar;51(3):365–369. doi: 10.1038/bjc.1985.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Conte P. F., Pronzato P., Rubagotti A., Alama A., Amadori D., Demicheli R., Gardin G., Gentilini P., Jacomuzzi A., Lionetto R. Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trial. J Clin Oncol. 1987 Mar;5(3):339–347. doi: 10.1200/JCO.1987.5.3.339. [DOI] [PubMed] [Google Scholar]
- Gray J. W., Dolbeare F., Pallavicini M. G., Beisker W., Waldman F. Cell cycle analysis using flow cytometry. Int J Radiat Biol Relat Stud Phys Chem Med. 1986 Feb;49(2):237–255. doi: 10.1080/09553008514552531. [DOI] [PubMed] [Google Scholar]
- Hug V., Johnston D., Finders M., Hortobagyi G. Use of growth-stimulatory hormones to improve the in vitro therapeutic index of doxorubicin for human breast tumors. Cancer Res. 1986 Jan;46(1):147–152. [PubMed] [Google Scholar]
- Krishan A., Frei E., 3rd Effect of adriamycin on the cell cycle traverse and kinetics of cultured human lymphoblasts. Cancer Res. 1976 Jan;36(1):143–150. [PubMed] [Google Scholar]
- Osborne C. K. Combined chemo-hormonal therapy in breast cancer: a hypothesis. Breast Cancer Res Treat. 1981;1(2):121–123. doi: 10.1007/BF01805864. [DOI] [PubMed] [Google Scholar]
- Weichselbaum R. R., Hellman S., Piro A. J., Nove J. J., Little J. B. Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine. Cancer Res. 1978 Aug;38(8):2339–2342. [PubMed] [Google Scholar]